 |
|
|
|
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
Short, and Getting
Shorter |
|
Here's an update for those who have
been following my latest trade on the NASDAQ 100. I jumped into QID
a couple of weeks ago on the premise the market was due for a correction,
and the NASDAQ 100 would participate in a big way. QID is an
ETF that trades inversely to QQQQ- the ETF for the NASDAQ 100.
If QQQQ goes up, QID goes down, and vice versa.
I picked up 2,000 shares at $38.67,
and have now been in and out of the money three times in a rather trendless
but fairly volatile market. The market appears pretty strong right now,
so this could be a fool's errand that will cost me some money. However,
after two months of pretty uninterrupted appreciation, I felt like the
market was ready to cool off for a bit.
Today, on a rally in the QQQQs,
I piled in a little deeper. QID closed at $35.53 today, so I'm down
about $4k there. However, this security has no problem swinging a point
or two in a day or two, so I'm not too concerned.
Here's a chart of the QQQQs.
There's a couple of things I like which suggest a move to the downside.
First, today's move represented a double top from the high made a few days
ago of $50.47.
Secondly, QQQQ has come back
up an filled two gaps left from back in December and January. I know they're
hard to see on the chart, but I didn't want to make it too big.
I hoping the upside in the market
is exhausted right now, and sellers will surface going into the weekend.
I haven't set my stop loss yet, but will look to do so if the market chugs
much higher from here. Of course, I could be totally misreading this, and
the market could simply power higher.
Today, just before the close, I added
50 July 50 QQQQ puts at $1.27 to my account. I was looking at the QID calls,
but they had a bigger premium, so I went with the QQQQ puts.
On the option trade, I'm not going
to be looking for a huge move- it's a $6400 additional investment, and
if I can scalp a few thousand dollars out of the trade I'll be happy. It
will lower my cost basis on the QID position. If it moves the other
way, I might choose to liquidate those options fairly quickly, take my
loss, and get out.
This trade is testing my patience
a bit. This trendless market is tough, with the dollar falling a bit today
and oil up $5, it seems like a correction might be imminent.
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
|
|
Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription.
Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.
To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best
way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable
email newsletter delivery.
Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.
If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.
| |
Ensure Newsletter Delivery |
|
|
To ensure newsletter delivery, you
can add any additional
email addresses you may have to the OTC Journal Member List. Receiving
the OTC Journal Newsletter in multiple locations is the best way of making
sure you don't miss the next investing or trading opportunity! For web
based email addresses, the OTC Journal recommends @yahoo.com or @aol.com
for timely and reliable email newsletter delivery.
Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition. |
|
|
|
| The OTC Journal Newsletter is an
independent electronic publication committed to providing our readers with
factual information on selected publicly traded companies. All companies
are chosen on the basis of certain financial analysis and other pertinent
criteria with a view toward maximizing the upside potential for investors
while minimizing the downside risk, whenever possible. Moreover, as detailed
below, this publication accepts compensation from certain of the companies
which it features. Likewise, this newsletter is owned by MarketByte, LLC.
To the degrees enumerated herein, this newsletter should not be regarded
as an independent publication.
Go
Here to view our compensation on every company we have ever covered,
or visit the following web address: http://www.otcjournal.com/disclosure/compensation/section/profile/
for our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/
for Trading Alerts.
(Insert specific company compensation
here)
All statements and expressions are
the sole opinions of the editors and are subject to change without notice.
A profile, description, or other mention of a company in the newsletter
is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable,
in no way do we represent or guarantee the accuracy thereof, nor the statements
made herein.
From time to time MarketByte, LLC
sells shares in the open market it receives as compensation for coverage
of client companies. Since the shares are received as compensation for
services as previously disclosed, and not for investment purposes, the
editors do not view the sale of the shares as contradictory to any advice
delivered in the content. This should be viewed as a conflict of interest
by shareholders or prospective shareholders of the client companies.
The editor, members of the editor's
family, and/or entities with which they are affiliated aside from MarketBtye
LLC itself, are forbidden by company policy to own, buy, sell or otherwise
trade stock for their own benefit in the companies who appear in the publication
unless specifically disclosed in the newsletter.
The Trustee of the MarketByte, LLC
Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested
approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”),
a limited partnership in which the MarketByte Pension Plan is a limited
partner. No one associated with the MarketByte Pension Plan has any knowledge,
information, or control as to any past, present, or future investment activities
of the Longview Fund. Longview ocassoinally refers companies to MarketByte,
LLC for possible coverage by one of the MarketByte, LLC publications, which
publications include the OTC Journal Newsletter. Longview may or may not
own shares in the companies that it so refers to MarketByte. MarketByte
has no information (outside of information readily accessible to the general
public such as SEC filings) as to whether Longview owns any shares in the
companies that it refers to MarketByte, LLC. The above relationships should
be viewed as a potential and/or actual conflict of interest by shareholders
and prospective shareholders of MarketByte, LLC client companies.
The profiles, critiques, and other
editorial content of the OTC Journal may contain statements that appear
foward relating to the expected capabilities of the companies mentioned
herein.
THE READER SHOULD VERIFY ALL CLAIMS
AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED.
INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS
OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT
THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.COM.
We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or
the National Association of Securities Dealers ("NASD") at http://www.nasd.com.
We also strongly recommend that you read the SEC advisory to investors
concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Disclaimer ID: Readers can review all public filings
by companies at the SEC's EDGAR page. The NASD has published information
on how to invest carefully at its web site. MarketByte LLC's mailing address
is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.
You
can unsubscribe from this list at any time by Clicking
Here. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?. |
|
|
|
Click Here to View the OTC Journal Disclosure
|
|
To subscribe to our newsletter, please enter your email address below.
Quotes are delayed 20 minutes.
|